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Background: To examine facilitators of dental smoking intervention practices in Japan, where smokeless tobacco is
rarely used, we evaluated the characteristics of dental care for smokers.
Methods: Community dentists volunteered to record the treated disease or encounter with patients that was
principally responsible for their dental care on the survey day. Patients were classified into groups receiving
gingival/periodontal treatment (GPT), caries/endodontic treatment (CET), prosthetic treatment (PRT), periodical
check-up/orthodontic treatment (POT), or other encounters/treatments. Potential effect of dentist clustering was
adjusted by incorporating the complex survey design into the analysis.
Results: Data of 2835 current smokers (CS) and 6850 non-smokers (NS) from 753 clinics were analysed. Distribution
of treatments significantly differed between CS and NS (P = 0.001). In ad hoc multiple comparisons for each
treatment, CS were significantly higher than NS for CET (47.1% vs. 43.6%, P = 0.002), and lower for POT (1.6% vs.
2.7%, P = 0.001), whereas GPT and PRT proportions were equivalent by smoking. When stage of disease progression
was compared in the GPT subpopulation, CS were more likely received treatment for advanced stage disease than
NS in the age groups of 40–59 years (24.9% vs. 15.3%, P = 0.001) and more than 60 years (40.8% vs. 22.1%, P < 0.001).
However, the difference was less apparent in the entire population (9.7% vs. 6.0%), and CS were not predominant
among patients receiving GPT for advanced stage disease (37.6%).
Conclusions: The association of smoking with type of dental care of CET and GPT severity would warrant the need for
dental professionals to engage their patients smoking within clinical practice. The detrimental effects of smoking in
dental care for smokers, as evidenced by the distribution of treatment and encounter and stage of treated disease,
may not be clearly realized by dental professionals, unless the smoking status of all patients is identified.
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Tobacco use is a modifiable risk behaviour in oral disease
development. Dental professionals are able to reduce the
oral and overall disease burden related to tobacco by
counselling their patients. To date, however, tobacco inter-
vention practices by community dental professionals have
been limited, and dental professionals may have not fully
embraced opportunities for tobacco use interventions [1],* Correspondence: haniokat@college.fdcnet.ac.jp
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reproduction in any medium, provided the oralthough tobacco use cessation clinical activities have been
developed in both dental and dental hygiene programs [2].
Within undergraduate dental education for tobacco use
interventions, the most important facilitator is evidence of
the effects of tobacco use on oral health [3], while screen-
ing guides an important visual tool of the effects of to-
bacco use on oral health, particularly mucosal lesions [4].
These activities have been mainly conducted in the United
States, where dental professionals may have been aware of
the detrimental effects of smokeless tobacco in the oral
cavity in their daily practice [5]. However, they are now
expanding globally based on evidence of the detrimentaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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European countries [6,7] and in Central Asia [8,9].
Numerous epidemiological studies have shown the
detrimental effects of smoking on oral health. The
Surgeon General Report in 2004 summarized evidence
regarding causality of the association between smoking
and oral health [10]. Evidence is sufficient to infer a
causal relationship with smoking for cancers of the oral
cavity and pharynx, and periodontitis. Evidence is sug-
gestive but not sufficient to infer a causal relationship
between smoking and root-surface caries and between
maternal smoking and oral clefts. Furthermore, smokers
have more missing teeth than non-smokers [11]. Dentist
awareness of evidence for the detrimental effects of
smoking during actual dental practice may promote
smoking cessation activity.
Characterization of dental care for smokers is likely
an important factor in determining whether community
dentists can actively participate in smoking cessation
interventions in countries in which smokeless tobacco
has rarely been used. Because smokers appear to experi-
ence dental disease more frequently than non-smokers,
smokers were more likely to have more perceived dental
needs compared with non-smokers [12]. However,
smokers are less likely to report dental visits than non-
smokers [13]. These contradictory findings hinder the
evaluation of the characteristics of dental care for smokers
in community dental clinics. To our knowledge, no study
has compared dental care between smokers and non-
smokers in community dental clinics. The aim of present
study was to clarify the characteristic of dental care of
smokers in community dental clinics Japan.Methods
Study design
To examine the characteristics of dental care for smo-
kers in community dental clinics, 1022 dentists were
randomly selected from among general practitioner
members of the Japan Dental Association. Each dentist
was notified by mail prior to sending the survey.
Dentists were provided with a survey form for data co-
llection, a cover letter outlining instructions on how to
complete the survey, and an addressed return envelope
for returning the completed survey. The patient survey
was conducted by each dentist on a designated day in
February 2008. Non-respondents were asked to com-
plete an identical survey in May or July 2008. Patients
aged ≥20 years who received dental care from the
dentist on the designated day were informed of the
study protocol and asked by their dentist about their
willingness to participate. The study protocol was ap-
proved by the Ethical Committee of Fukuoka Dental
College (Ethics Approval no. 115).Treated dental disease or patient encounters
Dental care can be determined by examining treated dis-
eases and patient encounters. Community dentists were
asked to report on treated diseases and patient encoun-
ters on the survey day using a questionnaire that was
identical to the Dental Clinic Questionnaire of the Pa-
tient Survey conducted in October 2005 by the Ministry
of Health, Labour and Welfare of Japan [14], except for
the items regarding smoking status. The treated diseases
and encounters were presented as specific codes that are
commonly used to describe dental diseases in the uni-
versal health insurance system in Japan.
Dentists were instructed to select one treated disease
or encounter per patient that was principally responsible
for the specific dental care on the survey day from a list
consisting of 15 items in the questionnaire (Table 1). For
example, periodontal disease progression was presented
as P1, P2 and P3, representing mild, moderate and severe
periodontal disease, respectively. These codes were de-
termined in accordance with the degree of alveolar bone
resorption, probing pocket depth and tooth mobility,
and are routinely used by community dentists in the
universal health insurance system of Japan. Since sub-
group analysis requires a sufficient number of patients
in each category, the 15 original items were classified
into 5 category groups to allow the estimation of cha-
racteristics of dental care for smokers, namely gingival/
periodontal treatment (GPT), caries/endodontic treat-
ment (CET), prosthetic treatment (PRT), periodical
check-up/orthodontic treatment (POT), and other en-
counters/treatments (OET).Determination of smoking status
The smoking status of patients was determined using a
self-administered questionnaire and defined as follows:
1) ‘current smoker’, an individual who currently smokes
and has smoked >100 cigarettes in his/her lifetime;
2) ‘former smoker’, an individual who has previously
smoked >100 cigarettes, but does not currently smoke;
and 3) ‘non-smoker’, an individual who has never smoked
or who has smoked ≤100 cigarettes. The use of oral/
smokeless tobacco was not assessed in this study because
this type of tobacco is rarely used or sold in Japan, and
was accordingly expected to have little impact on dental
care among our study patients.Statistical analyses
The sampling strategy of dental patients consisted of
two steps: selection of community dentists, and survey
by each dentist of his or her individual patients. Under
this complex survey design, community dentists were
established as the primary sampling unit of the stratum
in the analyses. Former smokers were excluded from
Table 1 Summarization of items for treated diseases and encounters
Category used for analysis Treated disease and encounter recorded in the questionnaire a)
Gum/periodontal treatment (GPT) Early stage b) Gingivitis
Mild to moderate periodontal disease c)
Advanced stage b) Severe periodontal disease c)
Caries/endodontic treatment (CET) Early stage b) Dental caries
Advanced stage b) Inflammation of dental pulp
Apical periodontitis
Periapical abscess and radicular cyst
Prosthetic treatment (PRT) Prosthetic treatment
Periodical check-up/orthodontic treatment (POT) Dental examination d)
Orthodontic treatment
Other encounters/treatments (OET) Other periodontal diseases e)
Other disorders of teeth and supporting structures
Other diseases of the oral region, salivary glands and jaws
Stomatitis and related lesions
Dental injuries
a) Items were recorded in the questionnaire on the survey day into five categories for analysis.
b) This category was used for analysis to compare the distribution of levels of treated diseases within the GPT and CET subpopulations.
c) Periodontal disease progression was presented as P1, P2 and P3 in the questionnaire, representing mild, moderate and severe periodontal disease, respectively.
These codes were adopted according to levels of alveolar bone resorption, probing pocket depth and tooth mobility, and are used by general dentists in the
universal health insurance system of Japan.
d) This category is mainly applicable to health check-ups.
e) This category is mainly applicable to pericoronitis and gingival abscess.
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former exposure to tobacco smoking would be difficult.
Analyses were conducted in two phases (Figure 1). Dis-
tribution of the five groups of treated disease and encoun-
ters was compared for smoking status by constructing a
5 × 2 contingency table using the chi-square test (Phase 1
analysis). When a significant difference was detected, five
2 × 2 contingency tables were constructed to test which
group(s) of treated disease and encounter significantly
contributed to the difference using the chi-square test. For
this analysis, the significance level was shared at P < 0.01
by the Bonferroni correction, since comparison was re-
peated five times.
In accordance with the level of progression of treated
disease, the GPT and CET patients were further divided
into two subgroups during the phase 2 analysis (Table 1).
The distribution of smoking status in the GPT and CET
subpopulations was tested according to progression of
the treated disease (Figure 1). Logistic regression models
were constructed for analysis of the GPT and CET sub-
populations. In the GPT model, dependent variables
were defined in a binary fashion, namely patients treated
for early stage disease (gingivitis and mild and moderate
periodontal diseases) = 0, and those treated for advanced
stage disease (severe periodontal disease) = 1; and in the
CET model, patients who were treated for early stage
disease (dental caries) = 0, and those treated for ad-
vanced stage disease (inflammation of dental pulp, apicalperiodontitis, periapical abscess, and radicular cyst) = 1.
When a significant interaction of smoking with gender
or age group (20–39 years, 40–59 years and ≥60 years)
was detected, the effect of smoking on the stage of
treated disease was examined by constructing models
stratified by gender/age groups. Adjusted odds ratios
(ORs) and 95% confidence intervals (95% CI) were cal-
culated according to smoking status and the stage of
treated disease by adjusting for gender/age groups.
The potential effect of dentist clustering was adjusted
for using statistical software (IBM SPSS Complex Samples
20.0, IBM Corp., New York, NY, USA). Significance level
was set at P < 0.05, except for the tests of multiple com-
parisons (P < 0.01).
Results
Of the 1,022 dentists that were mailed, 753 (73.7%)
responded to the survey. These dentists provided re-
cords for 14,187 patients, while those of 2,912 were
excluded because of incomplete information. Smoking
rate was measured at 25.1% (2,835/11,275). Former
smokers (n = 1,590) were not included in the analyses.
Finally, the data of 2,835 current smokers and 6,850
non-smokers were used to evaluate characteristics of
dental care for smokers vs. non-smokers in community
dental settings in Japan (Table 2).
Table 3, depicts the distribution of treated diseases and
encounters by smoking status in the phase 1 analysis. CET






































Figure 1 Analyses of the differences in dental care between current smokers and non-smokers. Analyses in the present study were
conducted in two phases, namely difference in the distribution of treated diseases or encounters (phase 1 analysis), and stage of disease
progression (phase 2 analysis). When a significant difference was detected in overall distribution (a), five additional 2 × 2 contingency tables were
prepared to estimate which group of treated diseases and encounters contributed to the difference in distribution by smoking status (b).
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(44.6%), followed by GPT (28.4%) and PRT (19.9%). The
overall distribution of the five groups significantly differed
by smoking (P = 0.001). The ad hoc test for each group
showed significant difference in CET (P = 0.002) and POT
(P = 0.001) by smoking, with current smokers more likely
received CET than non-smokers and less likely to receive
POT, though the differences were relatively small (47.1%
vs. 43.6% and 1.6% vs. 2.7%, respectively). In contrast, pro-
portions of GPT, PRT and OET was almost equivalentTable 2 Number of non-smokers and current smokers by
gender and age groups
Factor and category Number of patients
Non-smokers Current smokers Total
Gender
Male 1621 1944 3565
Female 5229 891 6120
Age group (years)
20–39 1425 889 2314
40–59 2055 1122 3177
≥60 3370 824 4194
Total 6850 2835 9685
Former smokers (n = 1590) were not included in the analysis.between portions of GPT, PRT and OET was almost
equivalent between non-smokers and current smokers
(28.8% vs. 27.7%, 20.3% vs. 19.0%, and 4.6% vs. 4.7%,
respectively).
In phase 2 of the analysis for the GPT subpopulation,
the participants age was identified as a significant factor
(P = 0.005). Ad hoc analyses were then performed in the
models stratified by age, at 20–39 years, 40–59 years, and
more than 60 years (Table 4), while the number of patients
increased with age (n = 489, 958, and 1,308, respectively).
While the proportion of advanced stage disease in current
smokers and non-smokers (4.1% vs. 4.4%) was similar in
the younger age group, current smokers in the older two
groups were more likely to receive treatment for advanced
stage disease than non-smokers (24.9% vs. 15.3% and
40.8% vs. 22.1%). These differences were significant, with
ORs adjusted for gender in the two older age groups of
1.67 (95% CI: 1.10–2.56, P = 0.001) and 2.25 (95% CI:
1.62–3.11, P <0.001). When the proportion was compared
based on the entire patient population aged more than
40 years, GPT for advanced stage disease accounted for
6.0% (324/5,425) of non-smokers and 9.7% (195/1,946) of
current smokers. Current smokers were not predominant
among patients treated with advanced stage disease, at
48.3% and 31.9% in the 40–59 and older than 60 years age
Table 3 Distribution of treated diseases and encounters by smoking status
Group according to treated disease
and encounter
Total % (n) Smoking status P-value
Non-smokers % (n) Current smokers % (n) All groups a) Per group b)
Gum/periodontal treatment (GPT) 28.4 (2755) 28.8 (1971) 27.7 (784) 0.001 0.299
Caries/endodontic treatment (CET) 44.6 (4324) 43.6 (2988) 47.1 (1336) 0.002
Prosthetic treatment (PRT) 19.9 (1929) 20.3 (1389) 19.0 (540) 0.155
Periodical check-up/ orthodontic treatment (POT) 2.4 (230) 2.7 (187) 1.6 (43) 0.001
Other encounters/treatments (OET) 4.6 (447) 4.6 (315) 4.7 (132) 0.902
Total 100 (9685) 100 (6850) 100 (2835)
a) Chi-square test for all groups.
b) Chi-square test for each group. Five 2 × 2 contingency tables were prepared to test differences in distribution by smoking. Since comparison was repeated five
times, significance level in this series was adjusted by Bonferroni correction, made by multiplying each p-value by 5. For convenience of interpretation,
significance level was retained at P < 0.05 throughout this table.
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40 years or more (data not shown).
In the analysis to test the distribution of CET level by
smoking status (Table 5), interactions with gender and age
groups were not significant. Current smokers were more
likely to receive treatment for advanced stage disease than
non-smokers (54.1% vs. 49.2%), and the difference was
significant, with an OR adjusted for age and gender of
1.39 (95% CI: 1.19–1.62, P < 0.001).
Discussion
In this study, we compared treated diseases and encoun-
ters among individual patients in community dental
clinics, and found that dental care for current smokers
and non-smokers in this setting differed. Current smokers
were significantly higher than non-smokers in distribution
for CET, and lower for POT, and more likely received
GPT for advanced stage disease than non-smokers inTable 4 Proportion of patients treated in the advanced stage
Age group a) (n)
smoking status
Stage of treated disease
Early stage b) (n, % ) Advanced stagec)
20-39 years (489)
Non-smokers 305 (65.2) 14 (66.7)
Current smokers 163 (34.8) 7 (33.3)
Total 468 (100) 21 (100)
40-59 years (958)
Non-smokers 516 (66.3) 93 (51.7)
Current smokers 262 (33.7) 87 (48.3)
Total 778 (100) 180 (100)
≥60 years (1308)
Non-smokers 812 (83.8) 231 (68.1)
Current smokers 157 (16.2) 108 (31.9)
Total 969 (100) 339 (100)
a) Because of significant interaction with age group (P = 0.005), logistic regression a
b) Patients treated for gingivitis and mild to moderate periodontal disease.
c) Patients treated for severe periodontal disease.
d) The proportion was compared by smoking status in the subpopulation receiving
e) Adjusted for gender.older age groups. Our hypothesis was that community
dentists in countries in which smokeless tobacco products
are rarely used may not realize the detrimental effects of
smoking. Therefore, the principal concept to discuss the
results should be focused on the characteristic of dental
care provided for current smokers. Consideration should
be given to health behaviour, particularly less frequent
visits to the dentist, although unmet needs of dental treat-
ment were beyond the scope of the present survey.
Our results showed that current smokers were more
likely to receive CET and less likely to receive POT than
non-smokers. This trend likely reflects the less effective
oral hygiene behaviours of smokers [15] and their less
frequent visits to dentists [9], respectively. However, since
the differences in distribution between non-smokers vs.
current smokers were relatively small, community dentists
may not realize the significance of these differences in
routine clinical settings.of gingival/periodontal disease progression
Proportion of
advanced stage d) (%)
Adjusted odds ratio e)







nalysis was performed in three models stratified by age group.
gingival/periodontal treatment in three age groups.
Table 5 Proportion of patients treated in the advanced stage of caries/endodontic disease progression
Smoking status Stage of treated disease Proportion of
advanced stage c) (%)
Adjusted odds ratio d)
(95% CI)Early stage a) (n) Advanced stage b) (n)
Non-smokers 1519 1469 49.2 1.00 (Reference)
Current smokers 613 723 54.1 1.39 (1.19–1.62)
a) Patients treated for dental caries.
b) Patients treated for inflammation of the dental pulp, apical periodontitis, periapical abscess, and radicular cyst.
c) The proportion was compared by smoking status in the subpopulation receiving caries/endodontic treatment.
d) Adjusted for age and gender.
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and PRT between current smokers and non-smokers was
similar. If the effects of smoking on periodontal disease
[16] and early tooth loss [17,18] in the Japanese popula-
tion are directly reflected in dental care, proportions of
GPT and PRT in current smokers would be higher than
those in non-smokers. Again, the less frequent visits by
smokers [13] may be responsible for the similarity in pro-
portions of GPT and PRT between current smokers and
non-smokers. Because gingival bleeding is suppressed in
smokers [19], smokers who were less likely aware of peri-
odontal disease may less likely to visit dentists than non-
smokers. Alternatively, certain cases receiving PRT would
be attributable to a severe form of periodontal disease.
Community dentists may not realize the detrimental ef-
fects of smoking from the distribution of treated diseases.
The characteristics of dental care for smokers due to
the detrimental effect of smoking may be reflected
within the GPT subpopulation, in which the proportions
of treatment for advanced stage disease in the two older
age groups were 15.3% vs. 24.9% and 22.1% vs. 40.8% for
non-smokers vs. current smokers. Dental professionals
may not recognize the detrimental effect of smoking
since non-smokers were still dominant among patients
receiving GPT for advanced stage disease, at 62.4% of
patients aged more than 40 years, albeit that former
smokers were excluded from analysis.
The characteristics of GPT in smokers may be less ap-
parent when the proportion is compared among the en-
tire patient population, 6.0% vs. 9.7%. The finding would
be more clearly reflected in the practice of periodontists,
who primarily treat periodontal patients. Among the
5,879 dentists who responded to the nationwide survey
in 2009 (response rate, 59%), the ratio of dentists who
reported items regarding smoking history in the medical
questionnaire and who routinely asked about smoking
status was about 30% for both; and although 90% agreed
that dentists should advise their patients to quit smo-
king, only 20% actually do so [20]. Thus, community
dentists may be unaware of the smoking status of their
patients, and may not recognize the detrimental effect of
smoking during GPT.
The deterioration of untreated dental caries often in-
volves more severe destruction of tooth structure, whichmay require endodontic-related treatment. Smokers may
be more likely to be treated for advanced stages of disease
of the tooth structure, but this may also reflect the less
frequent visits to dentists made by smokers [13]. However,
the frequent need for CET in smokers is in part likely a
reflection of the detrimental effects of smoking. The
Surgeon General Report in 2004 concluded that evidence
to infer the presence or absence of a causal relationship of
smoking with coronal dental caries is insufficient [10], and
the evidence that is available was based on epidemiological
studies which did not address possible confounders, and
inconclusive findings of salivary alteration. In other studies
that controlled for possible confounders, however, dental
caries were significantly and independently associated with
smoking [21-25]. A cohort study design may allow the
inference of causality [21], and the effects of exposure to
tobacco contents on the growth and metabolism of
Streptococcus mutans [26] and on the expansion of the
dental caries area [27] may suggest biological plausibility.
A mechanism which acts via this cariogenic microorgan-
ism is conceivable, since the effects of tobacco use on peri-
odontal microorganisms [28,29] has been recently added
to the list of potential causal pathways [30]. These reports
invite further studies to examine whether the potential
effect of smoking on tooth structure may influence oral
health inequalities.
Although current smokers experience tooth loss more
frequently than non-smokers [17,18,31], the proportion of
prosthetic treatments between smokers and non-smokers
in the present study was equivalent. The significant asso-
ciation of smoking with increased risk of prosthetic dental
restorations was independent of sociodemographic char-
acteristics, including education and income [32]. Our find-
ings regarding CET and GPT for advanced stage disease
in these subpopulations likely warrants further study re-
garding the intensity of PRT. Studies of Japanese workers
revealed that current smokers were more likely to incur
higher dental care costs than never or former smokers
[33]. The increased proportion of patients receiving care
for advanced stage conditions in the CET and GPT sub-
groups suggests the need for more intensive treatment in
smokers than non-smokers.
Several limitations of our study warrant mention. First,
a relatively high proportion of patients (20%) was excluded
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the excluded patients was similar to that of the included
patients (24.3% vs. 25.1%; data not shown), suggesting that
bias caused by the exclusion of data would be limited with
respect to smoking. Second, there is no information about
diagnosis and socioeconomic status in the present study.
Since we looked into treatments rendered by the question-
naire, it is thus difficult to draw concrete conclusions
about the exact diagnosis and prognosis. It is possible that
there is significant unmeasured confounding by socioeco-
nomic status. These variables should be included to com-
pare diagnosis and prognosis between current smokers
and non-smokers in community dental clinics. Third, the
survey was conducted on a single day and may have been
influenced by daily variations due to weather conditions
or weekly periodicity. Any effect of this single-day sam-
pling on the representativeness of dental patients might
have been small, however, given that patient distribution
for gender and age was similar to that in a patient survey
conducted by the Japanese Ministry of Health, Labour and
Welfare in October 2005.
Conclusions
The association of smoking with type of dental care of
CET and GPT severity would warrant the need for dental
professionals to engage their patients smoking within clin-
ical practice. The detrimental effects of smoking in dental
care for smokers regarding the distribution of treatments
and encounters and stage of disease at the time of treat-
ment might not be clearly realized by dental professionals
unless smoking status of all patients is identified.
Consent
Written informed consent by filling out the question-
naire was obtained from the patient for the publication
of this report.
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